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Objective
The obesity epidemic is escalating worldwide and if
present trends continue, is set to become the primary
cause of morbidity and mortality in the next decade.
Obesity has been linked to a spectrum of cardiovascular
abnormalities from subclinical changes in cardiac struc-
ture to overt heart failure, and has been liked to increased
cardiovascular mortality. Uncomplicated obesity (i.e.
obesity without any other co-morbidity or cardiovascular
risk factors) has been shown to cause increased left ven-
tricular mass and left ventricle dilatation. Our hypothesis
was that these changes are, at least in part, reversible fol-
lowing significant weight loss over one year.
Methods
Forty-four obese (eight male, thirty-six female, average
BMI 38.6 ± 7.2 SD) and 15 age, sex matched controls (BMI
21.9 ± 1.8 SD) underwent cardiac MR imaging at 1.5 Tesla
for the assessment of left ventricular mass (g), left ven-
tricular end-diastolic volume (EDV; ml), stroke volume
(SV; ml) and LV EF (%). All subjects were recruited on the
basis of no identifiable cardiac risk factors. There were no
significant differences in fasting glucose (5.2 ± 0.6 vs 4.9
± 0.4 mmol/L, p = 0.10), cholesterol (5.0 ± 0.8 vs 5.3 ± 0.9
mmol/L, p = 0.27), systolic blood pressure (121 ± 13 vs
115 ± 10 mmHg, p = 0.10) or diastolic blood pressure (76
± 8 vs 73 ± 8 mmHg, p = 0.09) between obese and normal
weight subjects, with all measurements remaining in the
normal range. Nineteen obese subjects underwent repeat
imaging after a one year period of weight loss (fourteen
with dietary intervention, five with roux-en-y gastric
bypass), averaging 17 ± 12% total body weight (range
3.5% to 47%). Only subjects with over 3% total body
weight reduction (n = 19) were included in the analysis.
Results
See Figure 1. Obesity per se was associated with elevated
left ventricular mass (126 ± 28 vs 92 ± 24 g; p < 0.001),
left ventricular mass indexed to height (75 ± 14 vs 54 ± 12
g/m; p < 0.001) and end-diastolic volume (146 ± 20 vs
122 ± 22 ml; p < 0.001). End-systolic volume and stroke
volume were also elevated in obesity (46 ± 12 vs 39 ± 11
ml; p = 0.035, and 100 ± 14 vs 83 ± 17 ml; p < 0.001,
respectively). Left ventricular ejection fraction was similar
between groups (68% vs 68%; p = 0.93). After weight loss,
there was a significant reduction in left ventricular mass
(by 14 ± 10 g; 134 ± 28 vs 120 ± 28 g; p < 0.001), left ven-
tricular mass indexed to height (79 ± 14 vs 71 ± 13 g/m; p
< 0.001). End-diastolic volume and end-systolic volume
were significantly smaller after weight loss (150 ± 24 vs
136 ± 22 ml; p < 0.001, and 45 ± 12 vs 40 ± 9 ml; p = 0.005
respectively). Left ventricular stroke volume was signifi-
cantly reduced after weight loss (105 ± 16 vs 96 ± 14 ml;
p = 0.001). Left ventricular ejection fraction was not
altered by weight loss (p = 0.663).
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Left ventricular hypertrophy is linked to increased mor-
bidity and all cause mortality, understanding the various
mechanisms responsible for reversal of left ventricular
hypertrophy is of great clinical importance. Cardiovascu-
lar mortality has been shown to be higher in obese indi-
viduals than normal weight individuals, and left
ventricular hypertrophy may be one potential mechanism
for this. Here we have shown in subjects with obesity in
the absence of identifiable cardiac risk factors, left ven-
tricular hypertrophy and left ventricular dilatation were
partially reversible after a one year period of significant
weight loss.
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